Stem Point Capital LP Portfolio Holdings

Stem Point Capital LP

  • $314 Billion
  • Q1 2025

Stem Point Capital LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $314 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $26B, Syndax Pharmaceuticals Inc with a value of $19.6B, Scholar Rock Holding Corp with a value of $18.2B, Arcellx, Inc. with a value of $18B, and Merus N.V. with a value of $14.6B.

Examining the 13F form we can see an decrease of $86.9B in the current position value, from $401B to 314B.

Stem Point Capital LP is based out at New York, NY

Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $314 Billion
Healthcare: $279 Billion
ETFs: $16.6 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.58B
$26 Billion 8.29% of portfolio
2,578,860
Q1 2025 Reduced 4.94%
$506M
$19.6 Billion 6.26% of portfolio
1,598,594
Q1 2025 Reduced 44.35%
$1.56B
$18.2 Billion 5.8% of portfolio
566,212
Q1 2025 Added 240.46%
$2.84B
$18 Billion 5.73% of portfolio
273,774
Q1 2025 New
$1.84B
$14.6 Billion 4.65% of portfolio
346,756
Q1 2025 Reduced 43.6%
$3.55B
$14.6 Billion 4.65% of portfolio
853,472
Q1 2025 Reduced 23.7%
$4.99B
$13.6 Billion 4.32% of portfolio
40,936
Q1 2025 New
$3.05B
$13.5 Billion 4.3% of portfolio
190,401
Q1 2025 Added 31.1%
$3.46B
$11.3 Billion 3.59% of portfolio
318,782
Q1 2025 Added 64.72%
$969M
$9.24 Billion 2.94% of portfolio
342,062
Q1 2025 Added 134.49%
$1.84B
$9.21 Billion 2.94% of portfolio
274,633
Q1 2025 Reduced 26.93%
$1.9B
$9.07 Billion 2.89% of portfolio
667,078
Q1 2025 Added 14.16%
$1.2B
$8.53 Billion 2.72% of portfolio
593,335
Q1 2025 Reduced 7.58%
$619M
$7.75 Billion 2.47% of portfolio
731,039
Q1 2025 Added 712.27%
$5B
$7.21 Billion 2.3% of portfolio
208,437
Q1 2025 New
Cg Oncology Inc
-
$7.1 Billion 2.26% of portfolio
-
Q1 2025 New
$820M
$6.88 Billion 2.19% of portfolio
440,073
Q1 2025 Reduced 12.16%
$9.11B
$6.64 Billion 2.12% of portfolio
87,059
Q1 2025 Reduced 18.34%
$1.83B
$6.32 Billion 2.02% of portfolio
156,185
Q1 2025 New
$5.13B
$6.35 Billion 2.02% of portfolio
192,352
Q1 2025 Reduced 53.87%
Biohaven LTD
-
$6.02 Billion 1.92% of portfolio
-
Q1 2025 Added 34.41%
$2.81B
$6.01 Billion 1.92% of portfolio
149,648
Q1 2025 Added 79.06%
$5.94B
$5.48 Billion 1.75% of portfolio
61,927
Q1 2025 New
Vistagen Therapeutics Inc
-
$5.11 Billion 1.63% of portfolio
-
Q1 2025 Added 1.63%
$38.8M
$5.07 Billion 1.62% of portfolio
1,190,579
Q1 2025 Added 258.18%
$288M
$4.46 Billion 1.42% of portfolio
386,837
Q1 2025 Reduced 61.04%
$935M
$3.97 Billion 1.26% of portfolio
180,255
Q1 2025 Added 35.83%
Surrozen Inc
-
$2.81 Billion 0.9% of portfolio
-
Q1 2025 Reduced 31.31%
Enliven Therapeutics Inc
-
$2.37 Billion 0.76% of portfolio
-
Q1 2025 Added 24.52%
$2.19B
$2.38 Billion 0.76% of portfolio
49,241
Q1 2025 Reduced 65.25%
$11.5B
$2.33 Billion 0.74% of portfolio
21,052
Q1 2025 New
$8.79B
$2.3 Billion 0.73% of portfolio
14,732
Q1 2025 New
Helix Acquisition Corp Ii
-
$2.27 Billion 0.72% of portfolio
-
Q4 2024 Added 0.45%
$1.67B
$2.19 Billion 0.7% of portfolio
268,919
Q1 2025 New
Spyre Therapeutics Inc
-
$2.2 Billion 0.7% of portfolio
-
Q1 2025 New
-
$2.14 Billion 0.68% of portfolio
-
Q1 2025 New
$3.63B
$1.79 Billion 0.57% of portfolio
33,816
Q1 2025 Reduced 83.74%
$462M
$1.63 Billion 0.52% of portfolio
467,882
Q1 2025 New
$457M
$1.53 Billion 0.49% of portfolio
960,307
Q1 2025 New
Perceptive Cap Solutions Cor
-
$1.55 Billion 0.49% of portfolio
-
Q2 2024 New
$832M
$1.1 Billion 0.35% of portfolio
66,999
Q1 2025 New
$2.81B
$955 Million 0.3% of portfolio
26,421
Q1 2025 New
$547M
$913 Million 0.29% of portfolio
124,523
Q1 2025 New
$605M
$883 Million 0.28% of portfolio
84,430
Q1 2025 New
Soleno Therapeutics Inc
-
$797 Million 0.25% of portfolio
-
Q1 2025 New
$78.7M
$740 Million 0.24% of portfolio
725,019
Q1 2025 New
$549M
$726 Million 0.23% of portfolio
89,833
Q1 2025 Reduced 87.54%
Solid Biosciences Inc
-
$733 Million 0.23% of portfolio
-
Q1 2025 New
Mbx Biosciences Inc
-
$713 Million 0.23% of portfolio
-
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $314 Billion
  • Prior Value $401 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 24 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email